Dentsply Sirona Inc (NAS:XRAY)
$ 13.75 +0.040 (+0.29%) Market Cap: 2.74 Bil Enterprise Value: 4.74 Bil PE Ratio: 0 PB Ratio: 1.41 GF Score: 58/100

Q4 2024 DENTSPLY SIRONA Inc Earnings Call Transcript

Feb 27, 2025 / 01:30PM GMT
Release Date Price: $17.15 (-8.83%)

Key Points

Positve
  • Dentsply Sirona Inc (XRAY) saw a return to organic sales growth in Europe, with approximately 2% growth in Q4 2024.
  • Global growth in Imaging was nearly 13%, indicating strong performance in this segment.
  • SureSmile continued to grow globally, achieving a nearly 4% increase over the prior year quarter, with over 20% growth in Europe for Q4 and the full year.
  • Wellspect exceeded estimated market growth rates, posting approximately 7% growth.
  • The company completed the largest individual phase of its ERP deployment in the US, which went live on November 1, 2024, laying important foundations for future phases.
Negative
  • Dentsply Sirona Inc (XRAY) recorded non-cash charges for the impairment of goodwill and other intangibles of approximately $370 million net of tax.
  • The voluntary suspension of sales and marketing of Byte aligners resulted in a charge for customer refunds, negatively impacting Q4 results.
  • Organic sales in the Orthodontic & Implant Solutions segment declined 28.7%, primarily driven by the impact from Byte.
  • US sales declined 29.9%, largely due to Byte, CAD/CAM, and the timing of EDS distributor orders.
  • The macro environment, challenging marketing, and competitive dynamics have created headwinds on organic sales, making the $3 adjusted EPS target unachievable in 2026.
Operator

Good day, and thank you for standing by. Welcome to the Q4 2024 Dentsply Sirona earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Andrea Daley, Vice President of Investor Relations.

Andrea Daley
DENTSPLY SIRONA Inc - Vice President, Investor Relations

Andrea Daley

Thank you, Josh, and good morning, everyone. Welcome to the Dentsply Sirona fourth quarter 2024 earnings call. Joining me for today's call is Simon Campion, Chief Executive Officer; Herman Cueto, Interim Chief Financial Officer; and Rich Rosenzweig, Executive Vice President, Corporate Development and General Counsel.

I'd like to remind you that an earnings press release and slide presentation related to the call are available in the Investors section of our website at www.dentsplypsirona.com. Before we begin, please take a moment to read the forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot